Bio-Matrix Scientific Group Appoints Dr. Geoffrey O'Neill -- Formerly of Cryo-Cell International as New Bio-Matrix President.SAN DIEGO -- Bio-Matrix Scientific Group Inc. today announced that it appointed Geoffrey O'Neill, Ph.D. as President of the Company. Dr. O'Neill most recently served as Director of Stem Cell Laboratories and Scientific Research for Cryo-Cell International Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : CCEL CCEL Christian Classics Ethereal Library ). Cryo-Cell International represents themselves as the world's largest U-Cord(R) stem cell banking firm. "The appointment of Dr. O'Neill as President of Bio-Matrix Scientific Group Inc. signals our Company's aggressive growth plans in stem cell research devices, biomedical devices and the continued growth in the development of our Stem Cell Cryogenic Banks," said Brian Pockett, Managing Director and COO of Bio-Matrix Scientific Group Inc. Dr. Geoffrey O'Neill received his Ph.D. in Immunology from the University of Glasgow The University of Glasgow (Scottish Gaelic: Oilthigh Ghlaschu, Latin: Universitas Glasguensis) was founded in 1451, in Glasgow, Scotland. in 1973. In 1974, he undertook post-doctoral training under the guidance of Dr. Robert A Good (who performed the first bone marrow transplantation Bone Marrow Transplantation Definition The bone marrow—the sponge-like tissue found in the center of certain bones—contains stem cells that are the precursors of white blood cells, red blood cells, and platelets. in a patient with immunodeficiency) at Memorial Sloan-Kettering Cancer Center The Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital. The main campus is located at 1275 York Avenue, between 67th and 68th Streets, with other locations in New in New York. Dr. O'Neill's field of study at Sloan-Kettering was transplantation immunobiology. Dr. O'Neill brings over twenty five years experience as a visionary and pioneer in his field, achieving recognition from his colleagues as the recipient of the Jean Julliard Prize for Outstanding Research from the International Society of Blood Transfusion The International Society of Blood Transfusion (ISBT) is a scientific society, founded in 1935, which aims to promote the study of blood transfusion, and to spread the know-how about the manner in which blood transfusion medicine and science best can serve the patient's interests. and International Society of Hematology, presented in Budapest, Hungary. He also received the JM Foundation Award, New York, for innovative research. Dr. O'Neill's academic career covers tenures such as Visiting Professor, NIH-RCMI Program, University of Puerto Rico Founded in 1903, the University of Puerto Rico (Universidad de Puerto Rico in Spanish, UPR) is the oldest and largest university system in Puerto Rico. Though Puerto Rico is not a U.S. , School of Medicine, San Juan; Associate Professor of Pathology and Assistant Medical Director, Transfusion Medicine, University of Miami This article is about the university in Coral Gables, Florida. For the university in Oxford, Ohio, see Miami University. The University of Miami (also known as Miami of Florida,[2] UM,[3] or just The U , Jackson Memorial Hospital Jackson Memorial Hospital (also known as "Jackson" or abbreviated "JMH") is a non-profit, tertiary care teaching hospital and the major teaching hospital of the University of Miami Leonard M. Miller School of Medicine in Miami, Florida. ; Visiting Professor, Institute of Immunology, University of Munich, FRG; Associate Professor of Graduate Medical Sciences, Cornell University School of Medicine New York. Having authored and co-authored over 90 publications in the field of bone marrow transplantation and stem cell biology, Dr. O'Neill brings to the company entrepreneurial and leadership skills necessary to explore and pioneer new technologies and innovative therapies. Complementing his extensive research activities and academic achievements, Dr. O'Neill also brings strong practical implementation skills to Bio-Matrix Scientific Group Inc. having held numerous directorships. As the Medical Director of Cryo-Cell, the first company to pioneer and commercialize family banking for umbilical cord blood umbilical cord blood Transplantation A source of primitive and stem cells that can be used to reconstitute BM destroyed by aplastic anemia or by RT or chemotherapy for CA, lymphoproliferative malignancies. See Bone marrow transplantation, Stem cell therapy. stem cells, Dr. O'Neill was a key component in establishing Cryo-Cell as a leader in its field. Dr. O'Neill's enthusiasm, expertise, vision and experience in cellular therapies and biomaterials catapults him to the forefront of biotechnology. Using his vast experience in stem cell technology, Dr. O'Neill is exploring ways to replace traditional cosmetic and reconstructive surgical procedures. Bio-Matrix Chairman David Koos, Ph.D. said, "We feel this addition definitely rounds out our management team and sends a message that we are serious about the Company's future and our commitment to it." A spokesperson for Bio-Matrix stated that Phil Watts, Ph.D., the Company's Director of Research and Development, will be working closely with Dr. O'Neill in developing next generation cryo-genic technology and other medical device technologies. More information will be available shortly on the Company's new web address www.BMXGonline.com. About Bio-Matrix Scientific Group Inc.: Bio-Matrix Scientific Group Inc. is a development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Other companies in the same industry as Bio-Matrix Scientific Group Inc. (Pink Sheets: BMXG) are StemCells Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : STEM), Thermogenesis thermogenesis /ther·mo·gen·e·sis/ (-jen´e-sis) the production of heat, especially within the animal body.thermogenet´icthermogen´ic ther·mo·gen·e·sis n. Corporation (NASDAQ: KOOL) and Regeneration Technologies Inc. (NASDAQ: RTIX). DISCLAIMER: This news release contains forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion